Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-004331
Filing Date
2025-04-02
Accepted
2025-04-02 17:00:35
Documents
93
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cycc-20241231x10k.htm   iXBRL 10-K 2370949
2 EX-4.12 cycc-20241231xex4d12.htm EX-4.12 170803
3 EX-19 cycc-20241231xex19.htm EX-19 70029
4 EX-23.1 cycc-20241231xex23d1.htm EX-23.1 2735
5 EX-31.1 cycc-20241231xex31d1.htm EX-31.1 13322
6 EX-31.2 cycc-20241231xex31d2.htm EX-31.2 16154
7 EX-32.1 cycc-20241231xex32d1.htm EX-32.1 6329
8 EX-32.2 cycc-20241231xex32d2.htm EX-32.2 9050
9 EX-97.1 cycc-20241231xex97d1.htm EX-97.1 34604
10 GRAPHIC cycc-20241231x10k001.jpg GRAPHIC 20054
11 GRAPHIC cycc-20241231x10k002.jpg GRAPHIC 34428
  Complete submission text file 0001558370-25-004331.txt   10408658

Data Files

Seq Description Document Type Size
12 EX-101.SCH cycc-20241231.xsd EX-101.SCH 78742
13 EX-101.CAL cycc-20241231_cal.xml EX-101.CAL 56394
14 EX-101.DEF cycc-20241231_def.xml EX-101.DEF 319329
15 EX-101.LAB cycc-20241231_lab.xml EX-101.LAB 572486
16 EX-101.PRE cycc-20241231_pre.xml EX-101.PRE 490574
96 EXTRACTED XBRL INSTANCE DOCUMENT cycc-20241231x10k_htm.xml XML 1551845
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 25805802
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)